Skip to main content

Table 2 Cox proportional hazards model for TCGA patients

From: A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

Characteristic Hazard ratio (95% CI) p value
CDKN2A alteration 2.7 (1.4–5.1) 0.002*
Unknown stage (reference) 1  
Localized tumor at diagnosis 0.42 (0.23–0.79) 0.007*
Metastasis at diagnosis 1.79 (1.06–3) 0.03*
Age at diagnosis 1.03 (1.01–1.05) 0.002*
Tumor size (cm) 1 (0.99–1.01) 0.053